You are here

Clinical Study Assessing a New Scale to Measure Onset of Action in Generalized Anxiety Disorder

Last updated on March 15, 2019

FOR MORE INFORMATION
Study Location
Pfizer Investigational Site
Glendale, California, 91206 United States
Contact
1-800-718-1021
Eligibility criteria
Condition
The disease, disorder, syndrome, illness, or injury that is being studied.
Anxiety Disorders
Sex
Females and Males
Age
Pediatric Trials: 0-17 Years
Adult Trials: 18+ Years
18-65 years
Inclusion criteria
The factors, or reasons, that allow a person to participate in a clinical study.
Show details

- Primary Diagnosis of GAD (DSM IV, 300.02) as established by the clinician using all
sources of data including the MINI structured interview

- HAM A score ³20 at the Screening (Study Day -7) and Baseline (Study Day 1) Visits by
observer rating

- Good health as determined by medical history, physical examination, vital signs,
electrocardiography (ECG), and clinical laboratory measurements

- Covi Anxiety Scale total score ³9 and Raskin Depression Scale total score £7 at the
Screening Visit (to ensure predominance of anxiety symptoms over depression symptoms)

- Age 18 to 65 (inclusive)

Exclusion criteria
The factors, or reasons, that prevent a person from participating in a clinical study.
Show details

- Patients with most other current DSM-IV Axis I disorders.

- Patients with current or past schizophrenia, Psychotic disorder

- Delirium, dementia, amnestic, and other clinically significant cognitive disorders

- Bipolar or schizoaffective disorder

- Benzodiazepine abuse or dependence; and/or Factitious disorder.

NCT00715039
Pfizer
Completed
Clinical Study Assessing a New Scale to Measure Onset of Action in Generalized Anxiety Disorder

NEED INFO?

Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center

Pfizer Clinical Trials Contact Center

1-800-718-1021

[email protected]

call now

Try a new search

Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.

FOR MORE INFORMATION

Contact a representative by phone, email, or visiting the study website. Please see the references below:

BY PHONE

Pfizer Clinical Trials Contact Center

1-800-718-1021

BY EMAIL

Contact

[email protected]

Call Now